Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept
Article in Clinical Immunology (May 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Innate immune modulation in transplantation: mechanisms, challenges, and opportunities
Article in Frontiers in Transplantation (December 2023)
Immunosuppressive Therapy and Nutritional Status of Patients after Kidney Transplantation: A Protocol for a Systematic Review
Article in Journal of Clinical Medicine (November 2023)